AHSG and cholangiocarcinoma: It is notable that a recent bioinformatic study reported the DNA methylation of AHSG and F2 also increased in CCA patients [38], meaning that it may be another molecular mechanism for decreasing RNA levels of AHSG and F2 in cancer.